SLGL
Sol-Gel Technologies Ltd

1,114
Mkt Cap
$187.2M
Volume
59,987.00
52W High
$76.80
52W Low
$4.02
PE Ratio
-20.83
SLGL Fundamentals
Price
$73.80
Prev Close
$67.20
Open
$65.70
50D MA
$53.82
Beta
0.47
Avg. Volume
22,385.45
EPS (Annual)
-$3.80
P/B
7.19
Rev/Employee
$339,352.94
$3.29
Loading...
Loading...

About

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
34

Frequently Asked Questions

What is Market Cap of Sol-Gel Technologies Ltd?
What is the 52-week high for Sol-Gel Technologies Ltd?
What is the 52-week low for Sol-Gel Technologies Ltd?
What is Sol-Gel Technologies Ltd stock price today?
What was Sol-Gel Technologies Ltd stock price yesterday?
What is the PE ratio of Sol-Gel Technologies Ltd?
What is the Price-to-Book ratio of Sol-Gel Technologies Ltd?
What is the 50-day moving average of Sol-Gel Technologies Ltd?
How many employees does Sol-Gel Technologies Ltd have?

Latest SLGL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.